首页> 外文期刊>Interventional cardiology. >Infectious complications of percutaneous cardiac procedures
【24h】

Infectious complications of percutaneous cardiac procedures

机译:经皮心脏手术的感染并发症

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Percutaneous coronary intervention (PCI) and interventional structural heart disease procedures have steadily increased worldwide over the last two decades. Patient infection is a potential complication of percutaneous cardiac procedures, but the incidence is very low due to the use of sterile techniques and percutaneous arterial puncture. Infection can be categorized as occurring at the access site, which includes vascular closure devices, or locally within the implanted device or a cardiac structure. Although rare, endovascular and cardiac infection can be challenging to diagnose and may have catastrophic consequences. In most cases, treatment requires prolonged parenteral antibiotics and surgical intervention. A comprehensive review of all reports of infection related to percutaneous cardiac procedures since 1994 is covered as are the current infection control guidelines.
机译:在过去的二十年中,经皮冠状动脉介入治疗(PCI)和介入性结构性心脏病治疗程序在全球范围内稳步增长。患者感染是经皮心脏手术的潜在并发症,但是由于使用了无菌技术和经皮动脉穿刺,其发生率非常低。感染可分类为发生在进入部位,包括血管闭合装置,或局部在植入装置或心脏结构内。尽管很少见,但血管内和心脏感染可能难以诊断,并可能造成灾难性后果。在大多数情况下,治疗需要长时间的肠胃外抗生素和手术干预。自1994年以来,对所有与经皮心脏手术相关的感染报告进行了全面回顾,同时涵盖了当前的感染控制指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号